Tenofovir Disoproxil Fumarate in the Management of Chronic B Infection in Children

Creative Commons License

GÜMÜŞ E., Karhan A. N., Hizarcioglu-Gulsen H., DEMİR H., Temizel İ. N.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.27, no.3, pp.142-147, 2021 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 3
  • Publication Date: 2021
  • Doi Number: 10.4274/vhd.galenos.2021.2020-11-2
  • Journal Name: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.142-147
  • Keywords: Antiviral, chronic hepatitis B infection, nucleos(t)ide analog, tenofovir disoproxil fumarate, CHRONIC HEPATITIS-B, LAMIVUDINE, ADOLESCENTS, CHILDHOOD, THERAPY, TRIAL
  • Hacettepe University Affiliated: Yes

Abstract

Objectives: The aim of this study was to present real-world data regarding the efficacy and safety of tenofovir disoproxil fumarate (TDF) in pediatric patients with chronic hepatitis B (CHB).